- Home
- KURA vs ABL Comparison
KURA vs ABL Comparison
Compare KURA & ABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- ABL
- Stock Information
- Founded
- KURA 2014
- ABL 2004
- Country
- KURA United States
- ABL United States
- Employees
- KURA N/A
- ABL N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- ABL Investment Managers
- Sector
- KURA Health Care
- ABL Finance
- Exchange
- KURA Nasdaq
- ABL Nasdaq
- Market Cap
- KURA 561.9M
- ABL 602.4M
- IPO Year
- KURA N/A
- ABL N/A
- Fundamental
- Price
- KURA $7.34
- ABL $6.41
- Analyst Decision
- KURA Strong Buy
- ABL Strong Buy
- Analyst Count
- KURA 13
- ABL 3
- Target Price
- KURA $24.45
- ABL $12.83
- AVG Volume (30 Days)
- KURA 1.5M
- ABL 619.5K
- Earning Date
- KURA 08-07-2025
- ABL 08-07-2025
- Dividend Yield
- KURA N/A
- ABL N/A
- EPS Growth
- KURA N/A
- ABL N/A
- EPS
- KURA N/A
- ABL N/A
- Revenue
- KURA $83,279,000.00
- ABL $161,724,466.00
- Revenue This Year
- KURA $125.04
- ABL $69.03
- Revenue Next Year
- KURA $83.75
- ABL $26.72
- P/E Ratio
- KURA N/A
- ABL N/A
- Revenue Growth
- KURA N/A
- ABL 69.56
- 52 Week Low
- KURA $5.41
- ABL $4.60
- 52 Week High
- KURA $21.57
- ABL $11.00
- Technical
- Relative Strength Index (RSI)
- KURA 67.38
- ABL 68.40
- Support Level
- KURA $5.45
- ABL $5.43
- Resistance Level
- KURA $6.74
- ABL $6.43
- Average True Range (ATR)
- KURA 0.38
- ABL 0.30
- MACD
- KURA 0.10
- ABL 0.14
- Stochastic Oscillator
- KURA 82.17
- ABL 98.44
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
About ABL Abacus Life Inc.
Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The Company organizes its business into five reportable segments Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. Its operations are confined to the United States.